Abstract
Substance P has been implicated as a mediator of inflammation. The involvement of this neuropeptide in carrageenan-induced hind paw edema in the rat was assessed. Subcutaneous injection of carrageenan into the rat paw caused a significant increase in substance P levels, which preceded the onset of inflammation. While injection of substance P alone caused mild edema, coadministration of submaximal doses of carrageenan and substance P resulted in a synergistic exacerbation in the degree of inflammation. This synergistic response was not detected when the nonamidated precursor of substance P was coinjected with carrageenan. The effects of substance P depletion on inflammation were also evaluated. In animals pretreated with capsaicin followed by injection with carrageenan, no significant increase in either the levels of substance P or the extent of edema was observed when compared to capsaicin-treated controls. These results indicate that substance P may play an important role in the early stages of carrageenan-induced paw edema and that a reduction in the biosynthesis of substance P may lessen the severity of this inflammatory response.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Greaves, M. W. 1988. Inflammation and mediators.Br. J. Dermatol. 119:419–426.
Flower, R. J., E. A. Harvey, andW. P. Kingston. 1976. Inflammatory effects of prostaglandin D2 in rat and human skin.Br. J. Pharmacol. 56:229–233.
Robertson, I., andM. W. Greaves. 1978. Responses of human skin blood vessels to synthetic histamine analogues.Br. J. Clin. Pharmacol. 5:319–322.
Juhlin, L., andS. Hammarstrom. 1982. Effects of intradermally injected leukotriene C4 and histamine in patients with urticaria, psoriasis and atopic dermatitis.Br. J. Dermatol. 170(Suppl. 23):106–110.
Helme, R. D., P. V. Andrews, andB. A. Watson. 1986. Neurogenic inflammation caused by wool fabric in the rat; Possible mediation by substance P.Neurosci. Lett. 66:333–337.
Tissot, M., P. Pradelles, andJ. P. Giroud. 1988. Substance-P-like levels in inflammatory exudates.Inflammation 12:25–35.
Raychaudhuri, A., C. Colombo, G. Pastor, M. Wong, andA. Y. Jeng, 1991. Effect of capsaicin on carrageenan-induced inflammation in rat pleurisy and exudate substance P. level.Agents Actions 34:251–253.
Levine, J. D., D. H. Collier, A. I. Basbaum, M. A. Moskowitz, andC. A. Helms. 1985. Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis.J. Rheumatol. 12:406–411.
Oku, R., M. Satoh, andH. Takagi. 1987. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats.Neurosci. Lett. 74:315–319.
Levine, J. D., R. Clark, M. Devor, C. Helms, M. A. Moskowitz, andA. I. Basbaum. 1984. Intraneuronal substance P contributes to the severity of experimental arthritis.Science 226:547–549.
Goetzl, E. J., T. Chernov, F. Renold, andD. G. Payan. 1985. Neuropeptide regulation of the expression of immediate hypersensitivity.J. Immunol. 135(Suppl):802S-805S.
Lotz, M., D. A. Carson, andJ. H. Vaughan. 1987. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis.Science 235:893–895.
Lotz, M., J. H. Vaughan, andD. A. Carson, 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes.Science 241:1218–1221.
Kimball, E. S., F. J. Persico, andJ. L. Vaught. 1988. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease.J. Immunol. 141:3564–3569.
Jessell, T. M., L. L. Iversen, andA. C. Cuello. 1978. Capsaicin-induced depletion of substance P from primary sensory neurones.Brain Res. 152:183–188.
Jeng, A. Y., M. Wong, S. J. Lovato, M. D. Erion, andJ. P. Gilligan. 1990. A radioimmunoassay for measuringα-amidating enzyme activity.Anal. Biochem. 185:213–219.
Buck, S. H., andT. F. Burks. 1986. The neuropharmacology of capsaicin: Review of some recent observations.Pharmacol. Rev. 38:179–225.
Jancso, N., A. Jancso-Gabor, andJ. Szolcsanyi. 1967. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin.Br. J. Pharmacol. Chemother. 31:138–151.
Gamse, R., P. Holzer, andF. Lembeck. 1980. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin.Br. J. Pharmacol. 68:207–213.
Colpaert, F. C., J. Donnerer, andF. Lembeck. 1983. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis.Life Sci. 32:1827–1834.
Lam, F. Y., andW. R. Ferrell. 1989. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist.Ann. Rheum. Dis. 48:928–932.
Lembeck, F., J. Donnerer, M. Tsuchiya, andA. Nagahisa. 1992. The nonapeptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation.Br. J. Pharmacol. 105:527–530.
Nagahisa, A., Y. Kanai, O. Suga, K. Taniguchi, M. Tsuchiya, J. A. Lowe, III, andH.-J. Hess. 1992. Antiinflammatory and analgesic activity of a nonapeptide substance P receptor antagonist.Eur. J. Pharmacol. 217:191–195.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilligan, J.P., Lovato, S.J., Erion, M.D. et al. Modulation of carrageenan-induced hind paw edema by substance P. Inflammation 18, 285–292 (1994). https://doi.org/10.1007/BF01534269
Issue Date:
DOI: https://doi.org/10.1007/BF01534269